Company profile
Kupando company profile
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity. The company's mission is to provide cancer patients with not only safe but also inexpensive immunotherapy, as well as to produce immunostimulatory drugs capable of preventing infectious illnesses.
Business identity
- Website
- https://www.kupando.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2018-01-01, Year
Headquarters
- Headquarters
- Schönefeld, Brandenburg, Germany
- Postal code
- 12529
- Country code
- DE
- Continent
- Europe